Company Filing History:
Years Active: 2018-2025
Title: Edmund Poon: Innovator in Antibody Therapeutics
Introduction
Edmund Poon is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of antibody therapeutics, holding a total of 3 patents. His work focuses on developing innovative solutions for treating diseases, including cancer and infectious diseases.
Latest Patents
One of his latest patents involves antibody molecules that bind CD137 and OX40. This application relates to antibody molecules that can agonize both CD137 and OX40. The antibody molecules feature a CDR-based binding site for CD137 and an OX40 antigen-binding site located in a constant domain of the antibody molecule. These innovative antibody molecules have potential applications in treating various diseases, such as cancer and infectious diseases. Another significant patent he holds is for therapeutic combinations comprising anti-CD73 antibodies and methods of using such combinations to reduce tumor-mediated immunosuppression. This invention features anti-CD73 antibodies, such as MEDI9447, in combination with A2A receptor inhibitors.
Career Highlights
Edmund Poon has worked with prominent companies in the pharmaceutical industry, including Medimmune Limited and Invox Pharma Limited. His experience in these organizations has contributed to his expertise in antibody development and therapeutic applications.
Collaborations
Throughout his career, Edmund has collaborated with talented individuals, including Michelle Morrow and Ross Anthony Stewart. These collaborations have likely enhanced his research and development efforts in the field of antibody therapeutics.
Conclusion
Edmund Poon is a distinguished inventor whose work in antibody therapeutics has the potential to impact the treatment of serious diseases. His innovative patents and collaborations reflect his commitment to advancing medical science.